Global Medical REIT Inc (NYSE:GMRE) – Equities researchers at Boenning Scattergood upped their Q4 2018 earnings per share (EPS) estimates for Global Medical REIT in a research note issued to investors on Wednesday, November 7th. Boenning Scattergood analyst M. Ross now anticipates that the company will post earnings of $0.24 per share for the quarter, up from their previous forecast of $0.23. Boenning Scattergood has a “Buy” rating and a $11.00 price objective on the stock.
Several other analysts have also recently issued reports on GMRE. Zacks Investment Research cut Global Medical REIT from a “buy” rating to a “hold” rating in a research report on Wednesday, July 25th. B. Riley set a $11.00 target price on Global Medical REIT and gave the company a “buy” rating in a research report on Friday, August 10th. Finally, Robert W. Baird assumed coverage on Global Medical REIT in a research report on Thursday, October 11th. They set an “outperform” rating and a $11.00 target price on the stock. One analyst has rated the stock with a sell rating and five have given a buy rating to the company’s stock. Global Medical REIT presently has an average rating of “Buy” and a consensus price target of $10.50.
Shares of NYSE:GMRE opened at $9.28 on Friday. Global Medical REIT has a 52-week low of $6.34 and a 52-week high of $10.05. The company has a market capitalization of $201.16 million, a P/E ratio of 17.19, a PEG ratio of 1.26 and a beta of 0.51. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 1.63.
Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings data on Monday, November 5th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.22). Global Medical REIT had a return on equity of 2.65% and a net margin of 9.87%. The firm had revenue of $14.00 million during the quarter, compared to the consensus estimate of $14.34 million.
A number of hedge funds and other institutional investors have recently made changes to their positions in GMRE. Citadel Advisors LLC bought a new stake in Global Medical REIT during the 2nd quarter valued at $194,000. Martingale Asset Management L P purchased a new stake in shares of Global Medical REIT during the 3rd quarter valued at $285,000. Schwab Charles Investment Management Inc. lifted its holdings in shares of Global Medical REIT by 32.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 37,600 shares of the company’s stock valued at $334,000 after purchasing an additional 9,200 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Global Medical REIT by 77.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 57,936 shares of the company’s stock valued at $403,000 after purchasing an additional 25,321 shares during the last quarter. Finally, Chicago Equity Partners LLC purchased a new stake in shares of Global Medical REIT during the 3rd quarter valued at $565,000. 42.01% of the stock is currently owned by institutional investors and hedge funds.
Global Medical REIT Company Profile
Global Medical REIT, Inc operates as a development stage company that intends to develop and manage a portfolio of healthcare real estate assets and properties. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Featured Article: Investing in Growth Stocks
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.